VERTEX PHARMAC. DL-,01/ US92532F1003 /
| 2024-11-07 10:58:11 PM | Chg. +4.400 | Volume | Bid10:58:11 PM | Ask10:58:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 464.200EUR | +0.96% | - Turnover: - |
464.200Bid Size: - | 466.100Ask Size: - | 119.78 bill.EUR | - | - |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 697.7150 | 698.3620 | 789.4370 | 812.0050 | 758.0850 | ||||||
| Intangible Assets | 284.3400 | 284.3400 | 29 | - | 400 | ||||||
| Long-Term Investments | - | 20.2760 | 20.4470 | - | - | ||||||
| Fixed Assets | 1,091.7220 | - | 897.0510 | 2,402.7890 | 3,495.6360 | ||||||
| Inventories | 57.2070 | 77.6040 | 111.8300 | 124.3600 | 167.5020 | ||||||
| Accounts Receivable | 177.6390 | 201.0830 | 281.3430 | 409.6880 | 633.5180 | ||||||
| Cash and Cash Equivalents | 714.7680 | 1,183.9450 | 1,665.4120 | 2,650.1340 | 3,109.3220 | ||||||
| Current Assets | 1,407.1530 | 1,831.5400 | 2,648.9630 | 3,843.1090 | 4,822.8290 | ||||||
| Total Assets | 2,498.8750 | 2,896.7870 | 3,546.0140 | 6,245.8980 | 8,318.4650 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 74.9420 | 61.4510 | 73.9940 | 110.9870 | 87.6100 | ||||||
| Long-term debt | 739.3970 | 521.3350 | 583.9020 | 581.5500 | 538.5760 | ||||||
| Liabilities to Banks | 224 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | 110.4000 | 134.1000 | 6.3000 | - | - | ||||||
| Liabilities | 1,405.2470 | 1,558.5960 | 1,503.7080 | 1,810.6950 | 2,233.2210 | ||||||
| Share Capital | 2.4270 | 2.4500 | 2.5120 | 2.5460 | 2.5890 | ||||||
| Total Equity | 1,093.6280 | 1,338.1910 | 2,042.3060 | 4,435.2030 | 6,085.2440 | ||||||
| Minority Interests | 153.6610 | 181.6090 | 13.7270 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 2,498.8750 | 2,896.7870 | 3,546.0140 | 6,245.8980 | 8,318.4650 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,032.3360 | 1,702.1770 | 2,488.6520 | 3,047.5970 | 4,162.8210 | ||||||
| Depreciation (total) | 62.3430 | 61.3980 | 61.3970 | 72.4200 | 106.9410 | ||||||
| Operating Result | -466.8790 | 9.9360 | 123.2430 | 635.1500 | 1,197.5660 | ||||||
| Interest Income | 84.2060 | 81.4320 | 57.5500 | 34.1190 | - | ||||||
| Income Before Taxes | -557.8000 | -67.3660 | -15.6890 | 600.2410 | 1,394.9190 | ||||||
| Income Taxes | 30.3810 | 16.6650 | -107.3240 | -1,486.8620 | 218.1090 | ||||||
| Minority Interests Profit | 31.8470 | -28.0210 | 171.8490 | 9.7930 | 0.0000 | ||||||
| Net Income | -556.3340 | -112.0520 | 263.4840 | 2,096.8960 | 1,176.8100 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -365.4320 | 236.1030 | 844.9420 | 1,270.2860 | 1,569.3300 | ||||||
| Cash Flow from Investing Activities | 268.8560 | 104.4690 | -437.6810 | -202.1580 | -1,235.3180 | ||||||
| Cash Flow from Financing | 188.9190 | 133.2710 | 68.4040 | -71.2190 | 126.7730 | ||||||
| Decrease / Increase in Cash | 89.5090 | 469.1770 | 481.4670 | 990.7270 | 462.4280 | ||||||
| Employees | 1,950 | 2,150 | 2,300 | 2,500 | 3,000 | ||||||
